Abeona Therapeutics Inc. (ABEO) is a clinical-stage novel biotherapeutics company engaged in the development of gene and cell therapies for life-threatening disorders. The lead product
On February 2, Abeona Therapeutics Inc. (ABEO) stock had increased by a further 7.14% premarket, at the last check. There is no official announcement or
On December 16, Abeona Therapeutics Inc. (ABEO) stock plunged by a further 22.15% in the after-hours on news of a public offering. The stock was
Abeona Therapeutics, Inc. (ABEO) stock prices were up 0.76% as of the market close on July 26th, 2021, bringing the price per share up to
Fuel Tech Inc. (FTEK) stock plunged -8.8% to $1.14 in the pre-market trading after the technology company offered advanced engineering solutions for the optimization of
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.